Cortical alpha-synuclein preformed fibrils do not affect interval timing in mice

Neurosci Lett. 2021 Nov 20:765:136273. doi: 10.1016/j.neulet.2021.136273. Epub 2021 Sep 30.

Abstract

One hallmark feature of Parkinson's disease (PD) is Lewy body pathology associated with misfolded alpha-synuclein. Previous studies have shown that striatal injection of alpha-synuclein preformed fibrils (PFF) can induce misfolding and aggregation of native alpha-synuclein in a prion-like manner, leading to cell death and motor dysfunction in mouse models. Here, we tested whether alpha-synuclein PFFs injected into the medial prefrontal cortex results in deficits in interval timing, a cognitive task which is disrupted in human PD patients and in rodent models of PD. We injected PFF or monomers of human alpha-synuclein into the medial prefrontal cortex of mice pre-injected with adeno-associated virus (AAV) coding for overexpression of human alpha-synuclein or control protein. Despite notable medial prefrontal cortical synucleinopathy, we did not observe consistent deficits in fixed-interval timing. These results suggest that cortical alpha-synuclein does not reliably disrupt fixed-interval timing.

Keywords: Alpha-synuclein; Interval timing; Preformed fibrils; Prion.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cerebral Cortex / pathology*
  • Cognition / physiology*
  • Female
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Synucleinopathies / pathology*
  • alpha-Synuclein / toxicity*

Substances

  • SNCA protein, human
  • alpha-Synuclein